Laser technology is changing the landscape of coloproctology, opening new possibilities for treating anorectal disorders with greater precision and less tissue damage. Conditions such as haemorrhoids, anal fistulas, anal fissures and pilonidal sinus have traditionally required surgical approaches associated with postoperative discomfort and extended recovery. The growing use of laser-assisted procedures is introducing alternatives that aim to reduce surgical trauma, limit bleeding and help patients return to normal activities sooner. As medical technology advances, laser surgery is attracting attention for its potential to improve treatment outcomes and reshape patient care in colorectal surgery.
The journey of laser surgery began with the development of the first working laser by Theodore Maiman in 1960. Its introduction into medicine opened fresh avenues for controlled tissue treatment, eventually reaching several surgical specialities. By the 1970s, carbon dioxide lasers had gained attention for their ability to cut tissue with precision and control bleeding. During the following decades, carbon dioxide and neodymium-doped yttrium aluminium garnet lasers found applications in proctological procedures. Improvements in laser delivery systems, energy control and surgical techniques gradually strengthened their clinical role, paving the way for less invasive approaches to selected anorectal conditions.
One of the most notable applications is laser haemorrhoidoplasty, which uses laser energy to shrink haemorrhoidal tissue while limiting damage to surrounding structures. Compared with conventional haemorrhoidectomy, the procedure may offer reduced postoperative pain, less bleeding and a quicker return to routine activities in appropriately selected patients. For anal fistulas, the Fistula Laser Closure technique delivers laser energy through the fistula tract to promote its closure while aiming to preserve the anal sphincter. This is particularly important because sphincter damage can lead to faecal incontinence. Laser-assisted procedures for pilonidal sinus and selected cases of chronic anal fissures are also being explored as alternatives to conventional treatment, although their suitability depends on the condition and its severity.
The appeal of laser-assisted proctology lies in its potential to combine targeted treatment with a less disruptive recovery. Conventional surgery remains effective for many patients, but tissue excision, postoperative wounds and prolonged wound care can create physical and practical challenges. Laser procedures may reduce these burdens in suitable cases, while precise energy delivery can help limit unnecessary tissue injury. However, the benefits are not uniform across every condition or patient. Treatment outcomes depend on disease complexity, the specific laser technique, the surgeon’s experience and appropriate patient selection. Recurrence, persistent symptoms and the need for further treatment remain possible, making careful clinical assessment essential before choosing a procedure.
Despite its promise, wider adoption of laser surgery faces significant hurdles. Advanced equipment requires substantial investment, while surgeons need specialised training to use it safely and effectively. Evidence also varies between procedures, and claims of consistently lower recurrence rates or superior long-term outcomes require stronger comparative research. Emerging developments, including robotic assistance, artificial intelligence-supported treatment planning and improved fibre-optic delivery systems, could refine precision and help clinicians tailor procedures to individual cases. These technologies remain evolving areas of development, and their clinical value must be established through rigorous evaluation rather than technological promise alone.
The future of laser technology in coloproctology will depend on balancing innovation with reliable clinical evidence. Larger comparative studies, longer follow-up periods and transparent reporting of complications, recurrence rates, treatment costs and patient satisfaction are needed to determine where laser procedures provide a meaningful advantage. For patients living with haemorrhoids, fistulas and other anorectal disorders, these techniques offer additional treatment possibilities, but they are not universal replacements for conventional surgery. A personalised approach that considers disease severity, expected benefits, potential risks and available expertise remains central to sound treatment decisions. With continued research and responsible clinical adoption, laser-assisted proctology could secure a stronger role in modern colorectal care.
